Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014

Publisher: John Wiley & Sons Inc

E-ISSN: 1527-3350|62|2|627-634

ISSN: 0270-9139

Source: HEPATOLOGY, Vol.62, Iss.2, 2015-08, pp. : 627-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract